About this trial
This Clinical trial will compare ICG cervical superficial injections versus superficial and deep injection for sentinel lymph node mapping in early-stage endometrial cancer patients
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women aged ≥18 years with a confirmed diagnosis of stage I endometrial cancer who underwent sentinel lymph node mapping with ICG at Barretos Cancer Hospital Treated using a minimally invasive approach (laparoscopic or robotic).
Disqualifiers
Allergic reaction of ICG and Iodo
Previous gynecologic oncology disease
Previous pelvic radiotherapy
Trial design
Parallel
Treatments tested in this trial
Superficial cervical ICG injection
Diagnostic testSuperficial ICG cervical injections
Deep and superficial ICG cervical injection
Diagnostic testDeep and superficial ICG cervical injection for sentinel lymph node mapping
Treatment groups
Trial outcomes
Primary outcomes
Rate of pelvic bilateral sentinel lymph detection with superficial ICG cervical injection compared to deep and superficial cervical injection
Our primary objective will be to compare the bilateral pelvic sentinel lymph node detection rates between superficial cervical injection of ICG and combined deep and superficial cervical injection.
Noninferiority of superficial ICG cervical injection for sentinel lymph node detection
The noninferiority of superficial cervical ICG injection compared with combined deep and superficial cervical injection for sentinel lymph node detection will be evaluated.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: